| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2007 | CN1306937C Multifunctional compound medicine for treating burn, chemical substance combustion and its skin disease |
| 03/28/2007 | CN1306936C Eye drop of tobramycin and sodium hyaluronate and its prepn process |
| 03/28/2007 | CN1306935C Vasopressin antagonist and oxytocin antagonist |
| 03/28/2007 | CN1306934C Pharmaceutical composition containing zaleplon and its preparation method |
| 03/28/2007 | CN1306933C Anisodamine ointment for treating frostbite and sclerema neonatorum and method for preparing same |
| 03/28/2007 | CN1306932C Medication for lowering level of endotoxin in human blood |
| 03/28/2007 | CN1306931C Capsule preparation |
| 03/28/2007 | CN1306929C Ultrapure oral fludara formulation with a fast releasing active substance |
| 03/28/2007 | CN1306919C Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 03/28/2007 | CN1306916C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 03/28/2007 | CN1306867C Ectoparasiticidal aqueous suspension formulations of Spinosyn |
| 03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
| 03/27/2007 | US7196220 Bone targeting compounds for delivering agents to the bone for interaction therewith |
| 03/27/2007 | US7196216 Reacting a solid from an aqueous alkaline solution of gagapentin hydrochloride with sulfuric acid; neutralizing with inorganic bases; dissolving the solid in protic solvent and isolating; salts removed by filtration/distillation; adding another solvent and isolating; simplification; industrial scale |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196195 8-chloro-6,11-dihydro-11-(4-piperidilydene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine); good solubility; anti-allergen |
| 03/27/2007 | US7196193 Reacting 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione with a metal hydride or a metal hydride complex (sodium borohydride); antiallergic and antihistamine; hydrazine free |
| 03/27/2007 | US7196180 Amide derivatives; scaffold for tissue regeneration; drug delivery biodegradable; tissue adhesive |
| 03/27/2007 | US7196179 gluconic acid reaction or hydrolysis of glucono delta lactone in water with lactic acid in the presence of calcium hydroxide ; hypocalcaemia, hyperparathyroidism, osteomalacia, rickets, symptomatic treatment of osteoporosis especially in menopause, to calcify in breast milk |
| 03/27/2007 | US7196119 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196117 Use of cationic surfactant as activity enhancer in deodorants and oral care |
| 03/27/2007 | US7196115 chemotherapeutic treatment is limited to ovarian, colon, breast and oral cancers |
| 03/27/2007 | US7196114 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
| 03/27/2007 | US7196113 Lactam tachykinin receptor antagonists |
| 03/27/2007 | US7196112 non-peptidic compounds that specifically inhibit the binding of ligands to VLA-4; inhibition, prevention and suppression of VLA-4-mediated cell adhesion, such as inflammation and immune reactions |
| 03/27/2007 | US7196111 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents |
| 03/27/2007 | US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 03/27/2007 | US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196107 Thia-and oxazoles and their use as ppars activators |
| 03/27/2007 | US7196106 Cyanothiophene derivatives, compositions containing such compounds and methods of use |
| 03/27/2007 | US7196105 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196103 Indole derivatives as factor Xa inhibitors |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196100 Opioid receptor antagonists |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196098 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/27/2007 | US7196096 Substituted amines of spirofuropyridines useful in therapy |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant |
| 03/27/2007 | US7196092 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196091 Tyrosine kinase inhibitors; controlling signal transduction; antitumor agents; benign prostate hyperplasia; respiratory system disorders |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/27/2007 | US7196088 5-HT6 modulators; such as 2-benzenesulfonyl-5-piperazin-1-yl-1,2,3,4-tetrahydroisoquinoline; |
| 03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
| 03/27/2007 | US7196086 Substituted dihydroquinazolines |
| 03/27/2007 | US7196085 Phthalazinone derivatives |
| 03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
| 03/27/2007 | US7196083 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors |
| 03/27/2007 | US7196082 Ophthalmic compositions for treating ocular hypertension |
| 03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196079 for treating, headache, migraine or cluster headache |
| 03/27/2007 | US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196077 Tachykinin antagonists |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196075 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/27/2007 | US7196073 polysaccharide binding to surface receptor on antigen presenting cells |
| 03/27/2007 | US7196072 High molecular weight polysaccharide fraction from Aloe vera with immunostimulatory activity |
| 03/27/2007 | US7196071 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/27/2007 | US7196069 High affinity RNA ligands of basic fibroblast growth factor |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7196066 eliciting an immune response in a subject by administering one or more large genomic DNA fragments; providing a core carrier coated with constructs carrying genomic DNA fragments obtained or derived from one or more pathogens |
| 03/27/2007 | US7196065 Enteral formulation |
| 03/27/2007 | US7196064 Compositions of plant carbohydrates as dietary supplements |
| 03/27/2007 | US7196055 Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
| 03/27/2007 | US7195914 Composition and method for treatment of hypertriglyceridemia |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195890 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 03/27/2007 | US7195885 Hepatitis C virus assays |
| 03/27/2007 | US7195879 Method for identifying modulators of NAv ion channels |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195868 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| 03/27/2007 | US7195791 Method for production of archidonic acid |
| 03/27/2007 | US7195790 Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid |
| 03/27/2007 | US7195787 Topical cosmetic |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195784 Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 03/27/2007 | US7195783 For treatment of depression, chronic/congestive heart failure, ischemia, arrhythmia, angina pectoris, hypertension, hypoinsulinemia, diabetes, hyperaldosteronemia, epilepsy, migraines, neurodegenerative disease, and/or preterm labor |
| 03/27/2007 | US7195779 Particularly levothyroxine sodium; unit dosage form containing an alditol, a saccharide, and optionally further excipients |
| 03/27/2007 | US7195778 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 03/27/2007 | US7195775 Protection of the female reproductive system from natural and artificial insults |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195773 Such as N-cyanomethyl-4-trifluoromethyl-3-pyridinecarboxyamide |
| 03/27/2007 | US7195769 Bioavailability |
| 03/27/2007 | US7195766 Product and process for liquefaction of mucus or sputum |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195756 Using fixed applicator with parasiticide to apply biological control agent to skin of rodents; treating and preventing tick infestation |
| 03/27/2007 | US7195752 Surfactant compounds and uses thereof |
| 03/27/2007 | US7195675 Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 03/27/2007 | CA2399976C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 03/27/2007 | CA2391953C Nervonic acid derivatives, their preparation and use |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |